Itacitinib for the Prevention of Graft Versus Host Disease
Clinical trial NCT04859946 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04859946
- Sponsor
- M.D. Anderson Cancer Center
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-11
- Primary completion
- 2027-04-01
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.